SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-283679
Filing Date
2023-11-28
Accepted
2023-11-28 07:16:33
Documents
22
Period of Report
2023-11-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d723036d8k.htm   iXBRL 8-K 35317
2 EX-99.1 d723036dex991.htm EX-99.1 14451
3 EX-99.2 d723036dex992.htm EX-99.2 19806
7 GRAPHIC g723036ex99_1p1g1.jpg GRAPHIC 332100
8 GRAPHIC g723036ex99_1p2g1.jpg GRAPHIC 702113
9 GRAPHIC g723036ex99_1p3g1.jpg GRAPHIC 309579
10 GRAPHIC g723036ex99_1p4g1.jpg GRAPHIC 382861
11 GRAPHIC g723036ex99_1p5g1.jpg GRAPHIC 384669
12 GRAPHIC g723036ex99_1p6g1.jpg GRAPHIC 313345
13 GRAPHIC g723036ex99_1p7g1.jpg GRAPHIC 321753
14 GRAPHIC g723036g1128043057705.jpg GRAPHIC 3760
  Complete submission text file 0001193125-23-283679.txt   3997323

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aldx-20231127.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20231127_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20231127_pre.xml EX-101.PRE 11262
16 EXTRACTED XBRL INSTANCE DOCUMENT d723036d8k_htm.xml XML 3356
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 231441889
SIC: 2834 Pharmaceutical Preparations